StockNews.com started coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Get Rating) in a report released on Thursday morning. The brokerage issued a strong-buy rating on the biopharmaceutical company’s stock. Vanda Pharmaceuticals Trading Up 1.5 % NASDAQ VNDA opened at $6.20 on Thursday. The firm has a market cap of $356.13 million, a price-to-earnings ratio […]